Cargando…

A Young Adult with Unintended Acute Intravenous Iron Intoxication Treated with Oral Chelation: The Use of Liver Ferriscan for Diagnosing and Monitoring Tissue Iron Load

Acute iron intoxication (FeI) in humans has not been adequately studied. The manifestation of FeI, defined as a serum iron concentration >300 μg/dL (55 μmol/L) within 12 hours of ingestion, include various symptoms appearing in progressive stages. Systemic toxicity is expected with an intake of 6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yassin, Mohamed, Soliman, Ashraf T, De Sanctis, Vincenzo, Moustafa, Abbas, Samaan, Sandra Abou, Nashwan, Abdulqadir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224804/ https://www.ncbi.nlm.nih.gov/pubmed/28101313 http://dx.doi.org/10.4084/MJHID.2017.008

Ejemplares similares

Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications
por: Kanbour, Ibrahim, et al.
Publicado: (2018)

Blood transfusion and iron overload in patients with Sickle Cell Disease (SCD): Personal experience and a short update of diabetes mellitus occurrence
por: Soliman, Ashraf T, et al.
Publicado: (2022)

Intravenous iron replacement therapy in eugonadal males with iron-deficiency anemia: Effects on pituitary gonadal axis and sperm parameters; A pilot study
por: Soliman, Ashraf, et al.
Publicado: (2014)

Liver Iron Content (LIC) in Adults with Sickle Cell Disease (SCD): Correlation with Serum Ferritin and Liver Enzymes Concentrations in Trasfusion Dependent (TD-SCD) and Non-Transfusion Dependent (NT-SCD) Patients
por: Yassin, Mohamed, et al.
Publicado: (2017)

Statural growth and prevalence of endocrinopathies in relation to liver iron content (LIC) in adult patients with beta thalassemia major (BTM) and sickle cell disease (SCD)
por: Yassin, Mohamed A, et al.
Publicado: (2018)

The impact of iron overload in patients with acute leukemia and myelodysplastic syndrome on hepatic and endocrine functions
por: Yassin, Mohamed A, et al.
Publicado: (2018)

Iron deficiency anemia and glucose metabolism
por: T Soliman, Ashraf, et al.
Publicado: (2017)

Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC
por: Soliman, Ashraf T, et al.
Publicado: (2018)

Jadenu(®) Substituting Exjade(®) in Iron Overloaded β-Thalassemia Major (BTM) Patients: A Preliminary Report of the Effects on the Tolerability, Serum Ferritin Level, Liver Iron Concentration and Biochemical Profiles
por: Yassin, Mohamed A, et al.
Publicado: (2018)

Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan
por: Garbowski, Maciej W, et al.
Publicado: (2014)

The Effects of Treatment with Blood Transfusion, Iron Chelation and Hydroxyurea on Puberty, Growth and Spermatogenesis in Sickle Cell Disease (SCD): A short update
por: Soliman, Ashraf T, et al.
Publicado: (2021)

Spontaneous iliopsoas hematoma in a trasfusion dependent β-thalassemia patient with hypersplenism: a case report
por: Aishwariya, Padmakumari, et al.
Publicado: (2019)

mRNA-based COVID-19 Vaccines Booster Dose: Benefits, Risks, and Coverage
por: Nashwan, Abdulqadir J., et al.
Publicado: (2022)

Prevalence and Significance of Leukopenia Induced by Intravenous Iron Therapy in a Large Cohort of Females with Iron Deficiency Anemia (IDA)
por: Almasri, Hussam A, et al.
Publicado: (2022)

Performance of Redox Active and Chelatable Iron Assays to Determine Labile Iron Release From Intravenous Iron Formulations
por: Pai, AB, et al.
Publicado: (2017)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Neutropenia and Lymphocytopenia Among Arab Females with Iron Deficiency Anemia (IDA) and their Response to Iron therapy
por: Yassin, Mohamed A., et al.
Publicado: (2022)

Chelation in Metal Intoxication
por: Flora, Swaran J.S., et al.
Publicado: (2010)

Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content
por: Yassin, Mohamed A., et al.
Publicado: (2019)

Iron Overload in Chronic Kidney Disease: Less Ferritin, More T2(*)MRI
por: Nashwan, Abdulqadir J., et al.
Publicado: (2022)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

The synthesis and properties of mitochondrial targeted iron chelators
por: Cilibrizzi, Agostino, et al.
Publicado: (2022)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

Iron Chelator or Iron Supplement Consumption in COVID-19? The Role of Iron with Severity Infection
por: Bastin, Alireza, et al.
Publicado: (2021)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Reversing oncogenic transformation with iron chelation
por: Abdelaal, Gina, et al.
Publicado: (2021)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Retrospective study on long-term effects of hormone replacement therapy (HRT) and iron chelation therapy on glucose homeostasis and insulin secretion in female ß- thalassemia major (β-TM) patients with acquired hypogonadotropic- hypogonadism (AHH)
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

Comparison of liver MRI R2(FerriScan®) VS liver MRI T2* as a measure of body iron load in a cohort of beta thalassaemia major patients
por: Padeniya, Padmapani, et al.
Publicado: (2020)

Iron Overload in Patients With Heavily Transfused Sickle Cell Disease—Correlation of Serum Ferritin With Cardiac T2(*) MRI (CMRTools), Liver T2(*) MRI, and R2-MRI (Ferriscan®)
por: Alkindi, Salam, et al.
Publicado: (2021)

Spinal cord compression secondary to extramedullary hematopoiesis: a rareness in a young adult with thalassemia major
por: Fareed, Shehab, et al.
Publicado: (2017)

Therapeutic Potential of Iron Chelating Therapy: Modification of Disease by Iron Depletion
por: Hershko, Chaim, et al.
Publicado: (1994)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis
por: Elli, Elena Maria, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a9ecpu0qpaerfle62mnh6lms7a